회사 개요
American Shared Hospital Services is a specialized entity within the healthcare sector that focuses on providing technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. The company operates specifically within the Medical Care Facilities industry, a segment critical for delivering high-precision treatment modalities to patients requiring radiosurgical interventions. Its operational scale is defined by a market capitalization of $8.78M and a trailing twelve-month revenue of $28.08M, while the number of employees is not disclosed in the available data. These valuation and revenue metrics indicate that the company functions as a small-cap enterprise with a niche market position, suggesting limited market penetration compared to larger diversified healthcare conglomerates but offering a focused exposure to the growing demand for advanced radiation therapy technologies.
재무 건전성
The company reported a revenue of $28.08M over the trailing twelve months, yet it recorded a net income of -$1,553,000, revealing a significant cost structure where operating expenses substantially erode profitability. Despite this net loss, the entity maintains an EBITDA of $3.70M, which suggests that while accounting for non-cash items and financing costs results in a loss, the core operational cash generation before interest and taxes remains positive. However, the free cash flow stands at -$3,995,500, indicating that the company is currently consuming cash rather than generating liquidity, which constrains its financial flexibility for capital expenditures or expansion without external financing. The gross margin of 38.3% demonstrates that the cost of goods sold is well-controlled relative to sales, but this is counterbalanced by an operating margin of -14.0% and a profit margin of -5.5%, highlighting significant overhead burdens or high depreciation costs typical in capital-intensive medical equipment leasing. On the balance sheet, total cash of $3.46M is insufficient to cover total debt of $21.67M, resulting in a debt-to-equity ratio of 78.27, which classifies the company as highly leveraged and reliant on debt financing. This leverage is further emphasized by a current ratio of 0.76, indicating that current assets fall short of current liabilities and signaling potential short-term liquidity pressures. Additionally, the return on equity is -9.4% and the return on assets is -2.2%, metrics that reveal management has not yet generated returns on shareholder capital or asset base, reflecting the transitional nature of the company's financial performance.
밸류에이션 평가
The valuation metrics present a complex picture, with a trailing P/E ratio of N/A due to negative earnings, while the forward P/E is calculated at 3.33, implying market expectations for a future recovery in profitability. The price-to-book ratio of 0.36 indicates that the market values the company at significantly less than its book value, suggesting a deep discount or potential undervaluation relative to net assets. Alternative valuation measures such as a price-to-sales ratio of 0.31 and an EV/EBITDA of 8.28 provide context that the stock trades at a fraction of its sales revenue and a compressed multiple relative to its EBITDA, often seen in distressed or turnaround situations. Regarding price action, the stock has traded between a 52-week high of $3.11 and a 52-week low of $1.29, with the current trading price sitting at a level that reflects the company's earnings volatility. The beta of 0.29 is notably low, indicating that the stock's price volatility is substantially lower than the broader market, which may offer a hedge against market downturns but also suggests limited upside potential during bull markets.
Growth & Income
The revenue growth year-over-year is -14.8%, while the earnings growth is N/A due to the absence of positive earnings in the prior period, indicating that the business is currently in a contraction phase rather than an expansion phase. Since the company is not a dividend payer with a dividend yield of N/A and a payout ratio of 0.0%, it does not distribute cash to shareholders, effectively reinvesting any generated cash flow or retaining earnings to address its debt obligations and operational challenges. The absence of a dividend confirms that the company prioritizes capital preservation and debt management over income distribution to investors, which is a common strategy for highly leveraged firms in the healthcare equipment sector. Overall, the company's growth and income profile is characterized by revenue contraction, negative profitability, and a lack of dividend income, positioning it as a high-risk asset with no current income component for investors seeking stability.